| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |